The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cardiovascular (CV) event risk in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide (ENZA) or abiraterone acetate (AA) in the United States (US).
 
Alan Bryce
Honoraria - Astellas Pharma; Bayer; Bayer; Janssen; Janssen Oncology; Lantheus Medical Imaging; Lilly; MOMA Therapeutics; Novartis; Novartis; Pfizer; Pfizer; Pfizer; Tolmar; Verity Pharmaceuticals
Consulting or Advisory Role - Astellas Pharma
Travel, Accommodations, Expenses - Bayer; Pfizer; Pfizer (Inst); Tolmar
 
Maelys Touya
Employment - Astellas Pharma
 
David Nimke
Employment - Astellas Pharma
 
Christopher Young
Employment - Astellas Pharma
 
Samantha Shao
Employment - Astellas Pharma; Novartis
Stock and Other Ownership Interests - Novartis
 
Nigel Rozario
Employment - Astellas Pharma
 
Pinal Kamdar
Employment - Astellas Pharma
 
Jasmina Ivanova
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Irene Varghese
Employment - Advi
Stock and Other Ownership Interests - Advi
 
Joerg Herrmann
Honoraria - Pfizer
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Mitsubihsi-Tanabe (Inst)
Patents, Royalties, Other Intellectual Property - Elsevier